Search Case Studies

Refine your results
1 - 10 results of 11 found.
  • Evidence for best practice within NHS Stop Smoking Services

    Research by UCL’s Professor Susan Michie and colleagues led to the establishment of the NHS Centre for Smoking Cessation and Training in 2009, estimated to have helped 7,500 smokers to quit, saving an estimated 6,500 life years.

  • Mentalization-based therapy: improving treatment for patients with borderline personality disorders

    Research at UCL led to the development of mentalization-based therapy, which has had a major impact on UK and international clinical practice treating self-harming, suicidal patients with a diagnosis of borderline personality disorder.

  • Cognitive Stimulation Therapy – a new therapy for dementia

    UCL research over the last 15 years has led to the development of an evidence-based group therapy for people with dementia, which has changed dementia care within the UK and worldwide.

  • Invention and commercial development of diagnostic tests of frontal lobe function

    Cognitive tests to detect dysfunction of the frontal lobes of the brain are used in clinics worldwide to improve diagnosis and clinical management of around 55,000 patients per year with neurological, psychiatric and developmental problems.

  • The Trauma Screening Questionnaire: improving the management of the psychological consequences of disasters and terrorism

    Research at UCL developed a ‘screen and treat’ model for dealing with mental health problems in the aftermath of disasters.

  • Using attachment research to improve the lives of vulnerable young children

    Research led to new assessment tools for measuring parent-child attachment that are now used in a variety of clinical services, innovative prevention and intervention programmes deployed throughout the world.

  • Improving the validity of autism spectrum disorder assessment

    A test for autistic spectrum disorders now included in healthcare guidelines and professional standards around the world, has significantly improved diagnosis of these conditions.

  • Increasing public awareness of and informing policy on the effects of recreational drug use

    UCL research on cannabis, ketamine and MDMA (ecstasy) has influenced government policy and legal proceedings in the UK and abroad.

  • Identifying the evidence base to support psychological interventions for schizophrenia

    Research at UCL has established the case for psychological interventions for schizophrenia; as a result, these interventions are now widely available, including in the NHS.

  • Creating neuropsychological assessments and services for Deaf patients with neurological impairments

    UCL research underpinned the development of resources and services for Deaf patients who use British Sign Language, including the establishment of the first neurology clinic for this group.

    1. 1
    2. 2